FDA Panel Discusses Approval of Alzheimer's Drug
A Food and Drug Administration advisory panel met to discuss regulatory approval for the Alzheimer's drug, Leqembi.
Data is currently not available
We couldn’t find any results matching your search.
Please try using other words for your search or explore other sections of the website for relevant information.
We’re sorry, we are currently experiencing some issues, please try again later.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.
now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Shares, Indexes, ETP and more asset classes.
Your Watchlist is empty.
Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.
Data is currently not available
Edit My Quotes
Data is currently not available
Edit My European Quotes
Data is currently not available
Your symbols have been updated
You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com.
Data is currently not available